Close

Alnylam Pharma (ALNY), Horizon Therapeutics (HZNP) and Mirati Therapeutics (MRTX) Are 2022 Top M&A Targets - Cantor Fitzgerald Dec 30, 2021 10:05AM
Mirati Therapeutics (MRTX) PT Raised to $85 at Cantor Fitzgerald Oct 29, 2019 06:45AM
Mirati Therapeutics (MRTX) PT Lowered to $81 at Cantor Fitzgerald Sep 9, 2019 06:42AM
Mirati Therapeutics (MRTX) PT Raised to $85 at Cantor Fitzgerald Jun 4, 2019 06:45AM
UPDATE: Cantor Fitzgerald Starts Mirati Therapeutics (MRTX) at Neutral Mar 5, 2019 06:35AM


Sep 19, 2017 04:30PM Mirati Therapeutics To Present At Upcoming Healthcare Conferences